Email this article Modern diagnostics of human papillomavirus infection: a review of worldwide research
- Authors: Orekhova Y.K.1, Khachaturyan A.R.2
-
Affiliations:
- EMC clinic
- St. Petersburg State Medical University named after academician I. P. Pavlov
- Issue: Vol 63, No 3 (2014)
- Pages: 82-89
- Section: Articles
- Submitted: 15.09.2014
- Published: 15.09.2014
- URL: https://journals.eco-vector.com/jowd/article/view/2664
- DOI: https://doi.org/10.17816/JOWD63382-89
- ID: 2664
Cite item
Open Access
Access granted
Abstract
The Human papillomavirus infection is a major risk factor for neoplastic processes of the cervix. In addition to a clinical examination of the cervix using a speculum and a light source, the cervix can be inspected using a variety of noninvasive and invasive diagnostic methods. In spite of this, clinical practice requires development and clinical of new disposable and highly informative methods for the detection of virus-induced cell proliferative activity to clarify the degree of neoplasia and manage the disease.
Full Text
About the authors
Yekaterina Konstantinovna Orekhova
EMC clinic
Email: orekhovakatherine@gmail.com
оbstetrician-gynecologist
Armine Robertovna Khachaturyan
St. Petersburg State Medical University named after academician I. P. Pavlov
Email: armine2709@rambler.ru
associate professor of the chair of Obstetrics and Gynecology
References
- Кравинская Т. А. Лечебно-диагностическая тактика при доброкачественных заболеваний шейки матки. Автореф. дис… канд. мед. наук. М.; 2009.
- Протасова А. Э. Клиническая оценка и фармакоэкономический анализ диагностики и лечения основных злокачественных опухолей женских гениталий в амбулаторных условиях. Автореф. дис… доктора мед. наук. СПб.; 2011.
- Роговская C. И. Папилломавирусная инфекция у женщин и патология шейки матки. М.: ГЭОТАР - Медиа; 2008.
- Савичева А. М. Проблемы диагностики и терапии репродуктивно значимых инфекций. Журнал акушерства и женских болезней. 2006; LV (2): 76-85.
- Савичева А. М., Шипицина Е. В. Вакцинация и скрининг: интеграция стратегий профилактики рака шейки матки. Журнал акушерства и женских болезней. 2009; LVIII (5): 90-1.
- Толибова Г. Х. Оценка эффективности метода автоматизированной жидкостной цитологии NOVAPREP в диагностике предопухолевых состояний шейки матки. В кн.: Материалы IV-ой ежегодной научной конференции молодых ученых и специалистов. Репродуктивная медицина: взгляд молодых. СПб.; 2013: 91-3.
- Фролова И. И., Бабиченко И. И. Клинико-морфологические исследования дискератозов шейки матки и цервикальных интраэпителиальных неоплазий. Вестник РУДН. 2004; 1 (25): 79-86.
- Шипицына Е. В., Оржесковская Е. А., Бабкина К. А., Савичева А. М., Микая Н. А., Орлова О. О., Юркова И. К. Определение вирусной нагрузки и статуса ДНК вируса папилломы человека 16 типа методом ПЦР в реальном времени. Журнал акушерства и женских болезней. 2004; LIII (4): 26-32.
- Abbott Molecular RealTime High Risk HPV Optimising Cervical Cancer Screening. Available at: http://www.abbottmolecular.com/products/infectious-diseases/realtime-pcr/hepatitis-high-risk-hpv-assay.html.
- Arbyn M., Bergeron C., Klinkhamer P. et al. Liquid compared with conventional cervical cytology a systematic review and meta-analysis. Obstet. Gynecol. 2008; 111 (1): 167-77.
- Cervical Cancer Screening and Human Papillomavirus (HPV) Testing Belgian Health Care Knowledge Centre. KCE reports. Vol. 38C. 2006.
- Campbell Ch., Menezes L., Paskett E., et al. Prevention of Invasive Cervical Cancer in the United States: Past, Present, and Future Cancer Epidemiology. N. Y.; 2012.
- High-Risk HPV DNA TestTM, An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68 in Cervical Specimens. 2004. P. 10.
- Franco E. L. Prognostic value of human papillomavirus in the survival of cervical cancer patients: an overview of the evidence cancer epidemiology//Biomarkers & Prevention. American Association for Cancer. 1992; 1: 499-504.
- Ho G. Y., Burk R. D., Klein S., Kadish A. S., Chang C. J., Palan P. et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl. Cancer. Inst. 1995; 87: 1365-71.
- Ikenberg Н., Bergeron Ch. et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J. Natl. Cancer.Inst. 2013; 1059 (20): 1550-7.
- Isacson Ch., Kessis Th., Hedrick L., et al. Both cell proliferation and apoptosis increase with lesion grade in cervical neoplasia but do not correlate with human papillomavirus type. Cancer Research. 1996;56: 669-74.
- Molano M., Van den Brule A., Plummer., et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am. J. Epidemiol. 2003;158: 486-94.
- Moscicki A. B. Impact of HPV infection in adolescent populations. J. Adolesc. Health. 2005; 37: S3-9.
- NHS Cervical Screening Programme. Public Health England. Available at: http://www.cancerscreening.nhs.uk/cervical/lbc.html.
- Ogunmodede F., Steven H. Yale et al. Human papillomavirus infections in primary care. Clinical Medicine Research. 2007; 5 (4): 210-7.
- Rebolj M., Lynge E. Incomplete follow-up of positive HPV tests: overview of randomised controlled trials on primary cervical screening. Br. J. Cancer. 2010;103: 310 -4.
- Russian Federation Human papillomavirus and related cancers. Fact Sheet. 2013 HPV information centre. 2014.
- Solomon D., Schiffman M., Tarone R. ALTS Study group/Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. J. Natl. Cancer Inst. 2001; 93:293-9.
- Tolibova G., Kvetnoy I., Khachaturian A., Polyakova V. Automated liquid-based cytology in Russia: evaluation of the efficiency in the diagnosis of pre-cancerous changes in the cervix”. Acta Cytologica. 2013; 57 (S1, 13): 81-2. (Abstracts 18th International Congress of Cytology, Paris, France, 26-30 May).
- World Health Organization, International Agency of Research on Cancer GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Geneva; 2012.
- World Health Organization, International Agency of Research on Cancer. Handbooks of cancer prevention. Cervix cancer screening. Geneva: IARC Press; 2005.
Supplementary files
